August 23, 2018 The Binding Site Group Ltd Andrea Thomas Regulatory Affairs Officer 8 Calthorpe Road Edgbaston Birmingham, B15
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
![A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S](https://journals.sagepub.com/cms/10.1177/0004563212473447/asset/images/large/10.1177_0004563212473447-fig1.jpeg)
A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g001.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
![Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis | Semantic Scholar Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b599f8a40f47cbd78b0733e7c1190c58cc49f39a/4-Figure2-1.png)
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis | Semantic Scholar
Diagnostika Pilipinas,Inc. - Check out our Freelite® and Hevylite® assays from The Binding Site, and learn how they can help with the diagnosis and monitoring of #MultipleMyeloma and other related diseases. Find
![Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients](https://www.degruyter.com/document/doi/10.1515/cclm-2018-1369/asset/graphic/j_cclm-2018-1369_fig_002.jpg)
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients
Freelite® Human Kappa Free kit For use on the Roche Cobas Integra® For in vitro diagnostic use Product Code: LK016.RI
![Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent](https://www.degruyter.com/document/doi/10.1515/cclm-2018-0412/asset/graphic/j_cclm-2018-0412_fig_001.jpg)